- Featured Product
- KD/KO Validated
ST6GAL1 Polyklonaler Antikörper
ST6GAL1 Polyklonal Antikörper für FC, IHC, IP, WB, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IP, IHC, IF, FC, ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 14355-1-AP
Synonyme
Galerie der Validierungsdaten
Geprüfte Anwendungen
Erfolgreiche Detektion in WB | Ramos-Zellen, HepG2-Zellen, HuH-7-Zellen, Jurkat-Zellen, Mauslebergewebe, Mausmilzgewebe, Raji-Zellen, Rattenlebergewebe, U-937-Zellen |
Erfolgreiche IP | Raji-Zellen |
Erfolgreiche Detektion in IHC | humanes Hautgewebe, humanes Kolonkarzinomgewebe, humanes Ovarialkarzinomgewebe Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen. |
Erfolgreiche Detektion in FC | Raji-Zellen |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunpräzipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunhistochemie (IHC) | IHC : 1:50-1:500 |
Durchflusszytometrie (FC) | FC : 0.20 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
KD/KO | See 4 publications below |
WB | See 9 publications below |
IHC | See 6 publications below |
IF | See 2 publications below |
Produktinformation
14355-1-AP bindet in WB, IP, IHC, IF, FC, ELISA ST6GAL1 und zeigt Reaktivität mit human, Maus, Ratten
Getestete Reaktivität | human, Maus, Ratte |
In Publikationen genannte Reaktivität | human, Maus, Ratte |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Polyklonal |
Typ | Antikörper |
Immunogen | ST6GAL1 fusion protein Ag5705 |
Vollständiger Name | ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
Berechnetes Molekulargewicht | 47 kDa |
Beobachtetes Molekulargewicht | 43-45 kDa, 50-70 kDa |
GenBank-Zugangsnummer | BC040009 |
Gene symbol | ST6GAL1 |
Gene ID (NCBI) | 6480 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Antigen-Affinitätsreinigung |
Lagerungspuffer | PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3. |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
ST6GAL1 (β-galactoside α-2-6 sialyl transferase1; also known as ST6N or CD75) is a sialyltransferase mediating the glycosylation of proteins and lipids to form functionally important glycoproteins and glycolipids in the Golgi compartment. It is principally expressed in liver, placenta and skeletal muscle. ST6GAL1 undergoes proteolytic process to generate soluble form from membrane form. Western blot analysis of human liver using this antibody detects both isoforms between 43-50 kDa. Higher molecular weight of bands around 50-70 kDa can also be observed with unknown reason. (PMID: 15049997)
Protokolle
Produktspezifische Protokolle | |
---|---|
WB protocol for ST6GAL1 antibody 14355-1-AP | Protokoll herunterladen |
IHC protocol for ST6GAL1 antibody 14355-1-AP | Protokoll herunterladen |
IP protocol for ST6GAL1 antibody 14355-1-AP | Protokoll herunterladen |
Standard-Protokolle | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
Species | Application | Title |
---|---|---|
Immunity Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma | ||
Int J Cancer Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
| ||
Mol Cell Proteomics Integrated Systems Analysis of the Murine and Human Pancreatic Cancer Glycomes Reveals a Tumor-Promoting Role for ST6GAL1
| ||
Front Oncol High-Risk HPV16 E6 Activates the cGMP/PKG Pathway Through Glycosyltransferase ST6GAL1 in Cervical Cancer Cells.
| ||
Am J Cancer Res α1,6-Fucosyltransferase (FUT8) regulates the cancer-promoting capacity of cancer-associated fibroblasts (CAFs) by modifying EGFR core fucosylation (CF) in non-small cell lung cancer (NSCLC). | ||
Int J Food Sci Nutr Ellagic acid alleviates TNBS-induced intestinal barrier dysfunction by regulating mucin secretion and maintaining tight junction integrity in rats |
Rezensionen
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
FH Vanessa (Verified Customer) (01-12-2024) | 1:1000 dilution of the primary antibody accompanied by the recommended blocking, washing and incubation steps resulted in crisp bands with no background.
|
FH Maggie (Verified Customer) (11-15-2023) | Overnight incubation
|
FH Faezeh (Verified Customer) (01-29-2023) | It showed two bands in A549 and PANC1 cell lines, we validated that top band is the correct one using siRNA against ST6GAL1.
|
FH Dawn (Verified Customer) (02-22-2022) | It is difficult to find good antibodies for glycoslytransferase genes, but this is a good one. It works in multiple cell lines as well.
|
FH Patricia (Verified Customer) (02-25-2020) | Did not work- even for positive control
|